Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same author

Super-Resolution Ultrasound Based Cell Tracking With Polymeric Nanobubbles.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics.

Chemical Society reviews·2026
Same author

Validation of an automated AI-based micro-CT organ segmentation workflow against expert annotations and its impact on fluorescence quantification.

European radiology experimental·2026
Same author

Future Challenges of Molecular Imaging in Oncology.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Molecular Ultrasound Imaging.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026

Related Experiment Video

Updated: May 29, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Macromolecular nanotheranostics for multimodal anticancer therapy.

Ruben Huis In 't Veld1, Gert Storm, Wim E Hennink

  • 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.

Nanoscale
|September 9, 2011
PubMed
Summary
This summary is machine-generated.

N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers are advanced drug delivery systems. These macromolecular nanotheranostics show promise in enhancing combination therapies for improved cancer treatment efficacy.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Area of Science:

  • Polymer chemistry and nanomedicine
  • Drug delivery systems
  • Biocompatible materials

Background:

  • N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers are well-established drug delivery systems.
  • HPMA copolymers exhibit prolonged circulation and selective tumor accumulation via the Enhanced Permeability and Retention (EPR) effect.
  • While effective in preclinical models, HPMA-based nanomedicines in patients primarily reduce toxicity rather than enhance efficacy.

Purpose of the Study:

  • To investigate the potential of HPMA-based nanomedicines for combination therapies.
  • To evaluate the efficacy of macromolecular nanotheranostics in improving cancer treatment outcomes.
  • To demonstrate the utility of nanomedicine formulations in enhancing radiochemotherapy and chemotherapy combinations.

Main Methods:

  • Utilized HPMA copolymers as macromolecular carriers for drug and imaging agents.
  • Employed various imaging agents and techniques to assess biodistribution and tumor targeting.
  • Investigated the efficacy of nanotheranostics in combination with chemotherapy and radiotherapy in preclinical models.

Main Results:

  • HPMA copolymers demonstrated prolonged circulation and effective, selective tumor accumulation.
  • HPMA-based nanotheranostics showed significant tumor growth inhibition in animal models.
  • Combination therapies utilizing nanomedicine formulations improved the efficacy of radiochemotherapy and chemotherapy.

Conclusions:

  • HPMA-based macromolecular nanotheranostics are suitable for combination therapies due to their biocompatibility and biodistribution.
  • These nanomedicines can enhance the efficacy of existing cancer treatment regimens.
  • The findings support the development of nanomedicine-guided combination therapies for improved cancer treatment outcomes.